It is well established that DLBCL and CLL cells display chronic BCR signaling, leading to constitutive activation of different signaling pathways, including the PLCγ2 pathway, which leads to the production of IP3 in basal conditions [23–25]. This evidence concerns the gene PLCG2 and diffuse large B-cell lymphoma.